2Simon M,Argiris A,Murren JR.Progress in the therapy of small cell lung cancer(J).Crit Rev Oncol Hematol,2004;49(2):119-33. 被引量：1
3Noda K,Nishiwaki Y,Kawahara M,et al.Irinotecan plus cisplatin com-pared with etoposide plus eisplatin for extensive small-cell lung cancer(J).N Engl J Med,2002;346(2):85-91. 被引量：1
4Nishiwaki Y,Kawahara M.Irinotecan plus cisplatin complatin com pared with etoposide pule cisplatin for extensive small-cell lung cancer(J).N Engl J Med,2002;346(2):126-8. 被引量：1
5Pinson P,Joos G,Watripont P,et al.Serum neuron specific enolase as a tumor maker in the diagnosis and follow up of small cell lung cancer(J).Respiration,1997;64(1):102-7. 被引量：1
同被引文献40
1OKAMOTO H,WATANABE K,KUNIKANE H,etal.Randomised phase III trail of carboplatin plus etopo-side vs split doses of ciaplatin plus etoposide in elderlyor poor-risk patients with extensive diseases small-celllung cancer:JCOG 9702[J].Br J Cancer,2007,97(2):162-169. 被引量：1
2Noda K,Nishiwaki Y,Kawahara M,et al.Irinotecanplus cisplatin compared with etoposide plus eisplatin forextensive small-cell lung cancer[J].N Engl J Med,2012,346(2):85-91. 被引量：1
3O'Brien ME,Ciuleanu TE,sekov H,et al.PhaseⅢtrial comparing supportive care alone with supportivecare with oral topotecan in patients with relapsed small-cell lung cancer[J].J Clin Oncol,2006,24(34):5441-5447. 被引量：1
4Eckardt JR,von Pawel J,Papai Z,et al.Open-label,multicenter,randomized,phaseⅢstudy comparing oraltopotecan/cisplatin versus etoposide/cisplatin as treat-ment for chemotherapy-naive patients with extensive-disease small-cell lung cancer[J].J Clin Oncol,2006,24(13):2044-2051. 被引量：1
